{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:00:08Z","timestamp":1790708408754,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["PB-PG-0317-20024"],"award-info":[{"award-number":["PB-PG-0317-20024"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pregnancy in women living with sickle cell disease (SCD) is associated with increased risk of morbidity and mortality for mother and baby. Outside of pregnancy, serial prophylactic exchange blood transfusion (SPEBT) has proven efficacy as a treatment for acute SCD complications, however, there is inadequate evidence for the safety and benefit for SCD during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To explore health professionals and women\u2019s view on the acceptability and feasibility of a randomised control trial of SPEBT versus usual care in pregnant women with SCD (Transfusion Antenatally in Pregnant women with SCD\u2014TAPS2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured telephone interviews were conducted with TAPS2 trial participants, trial decliners and clinical staff working on the TAPS2 trial. Interviews were analysed using reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We interviewed 19 trial participants, 12 trial decliners and 15 clinical staff. Three overarching themes were identified. First, factors affecting patient decisions on participation. These included personal benefit, particularly the hope that SPEBT would lead to a healthier pregnancy\u2014and altruistic motivations to help other women with SCD. Factors deterring women from participating included concerns about potential risks of SPEBT, for example infection, side effects, or transfusion reactions. Second, experiences of the TAPS2 trial varied. Participants allocated to SPEBT recounted perceived health benefits as well as \u2018expected\u2019 side effects. The time and cost involved in attending transfusion sessions had been difficult for some. Clinical staff at some sites reported that pressures on local apheresis capacity made delivering the intervention challenging. Third, interviews provided recommendations to inform the design of a future definitive RCT of SPEBT versus usual care, including suggestions to maximise participant recruitment. Suggested strategies included the provision of accessible, evidenced-based patient education to patients, partners and families to enable informed decision-making. There was strong support for including an observational arm in any future trial to enable patients unwilling, or unable, to be randomised to take part.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients\u2019 views on blood transfusions emerged as a key determinant in whether they chose to take part in this feasibility trial. Addressing pregnant SCD women\u2019s treatment concerns and preferences is key to maximising recruitment and retention in future trials. Addressing information gaps or misinformation through accessible patient education is needed. Including an observational study arm as part of a future definitive RCT, along with other highlighted strategies, will ensure that the evidence base and understanding of clinical outcomes in pregnant women with SCD is maximised for future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      NIH registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">www.clinicaltrials.gov<\/jats:ext-link>\n                      ), registration number NCT03975894 (registered 05\/06\/19); ISRCTN (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.isrctn.com\" ext-link-type=\"uri\">www.isrctn.com<\/jats:ext-link>\n                      ), registration number ISRCTN52684446 (retrospectively registered 02\/08\/19).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09244-5","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:55:57Z","timestamp":1783058157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The acceptability and feasibility of a randomised controlled trial of serial prophylactic exchange blood transfusion versus usual care in pregnant women with sickle cell disease: a qualitative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Laura L.","family":"Oakley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-2116","authenticated-orcid":false,"given":"Clare","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-3569","authenticated-orcid":false,"given":"Vicky","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-2909","authenticated-orcid":false,"given":"Eugene","family":"Oteng-Nim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-2364","authenticated-orcid":false,"given":"Sarah B.","family":"Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"10091","key":"9244_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390(10091):311\u201323.","journal-title":"Lancet"},{"issue":"16","key":"9244_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561\u201373.","journal-title":"N Engl J Med"},{"issue":"2","key":"9244_CR3","doi-asserted-by":"publisher","first-page":"e26829","DOI":"10.1002\/pbc.26829","volume":"65","author":"L Nahata","year":"2018","unstructured":"Nahata L, Caltabellotta NM, Ball K, O\u2019Brien SH, Creary SE. Desire for parenthood and reproductive health knowledge in adolescents and young adults with sickle cell disease and their caregivers. Pediatr Blood Cancer. 2018;65(2):e26829.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"9244_CR4","doi-asserted-by":"publisher","first-page":"e30359","DOI":"10.1002\/pbc.30359","volume":"70","author":"A-C Radauer-Plank","year":"2023","unstructured":"Radauer-Plank A-C, Diesch-Furlanetto T, Schneider M, Sommerh\u00e4user G, Friedrich LA, Salow V, et al. Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies. Pediatr Blood Cancer. 2023;70(7):e30359.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"9244_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/bjh.13270","volume":"169","author":"E Oteng-Ntim","year":"2015","unstructured":"Oteng-Ntim E, Ayensah B, Knight M, Howard J. Pregnancy outcome in patients with sickle cell disease in the UK \u2013 a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease. Br J Haematol. 2015;169(1):129\u201337.","journal-title":"Br J Haematol"},{"issue":"21","key":"9244_CR6","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","volume":"125","author":"E Oteng-Ntim","year":"2015","unstructured":"Oteng-Ntim E, Meeks D, Seed PT, Webster L, Howard J, Doyle P, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015;125(21):3316\u201325.","journal-title":"Blood"},{"issue":"1","key":"9244_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1182\/hematology.2019000039","volume":"2019","author":"K Smith-Whitley","year":"2019","unstructured":"Smith-Whitley K. Complications in pregnant women with sickle cell disease. Hematology. 2019;2019(1):359\u201366.","journal-title":"Hematology"},{"issue":"2","key":"9244_CR8","doi-asserted-by":"publisher","first-page":"e2254552-e22545","DOI":"10.1001\/jamanetworkopen.2022.54552","volume":"6","author":"ML Early","year":"2023","unstructured":"Early ML, Eke AC, Gemmill A, Lanzkron S, Pecker LH. Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012-2018. JAMA Netw Open. 2023;6(2):e2254552\u2013e2254552.","journal-title":"JAMA Netw Open"},{"key":"9244_CR9","doi-asserted-by":"crossref","unstructured":"Jain D, Atmapoojya P, Colah R, Lodha P. Sickle cell disease and pregnancy. Mediterranean journal of hematology and infectious diseases. 2019;11(1):e2019040.","DOI":"10.4084\/mjhid.2019.040"},{"issue":"3","key":"9244_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ajh.26818","volume":"98","author":"OO Adesina","year":"2023","unstructured":"Adesina OO, Brunson A, Fisch SC, Yu B, Mahajan A, Willen SM, et al. Pregnancy outcomes in women with sickle cell disease in California. Am J Hematol. 2023;98(3):440\u20138.","journal-title":"Am J Hematol"},{"issue":"3","key":"9244_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/tme.12447","volume":"28","author":"J Sharif","year":"2018","unstructured":"Sharif J, Byrd L, Stevenson K, Raddats J, Morsman E, Ryan K. Transfusion for sickle cell disease in pregnancy: a single-centre survey. Transfus Med. 2018;28(3):231\u20135.","journal-title":"Transfus Med"},{"issue":"6","key":"9244_CR12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/bjh.17671","volume":"194","author":"E Oteng-Ntim","year":"2021","unstructured":"Oteng-Ntim E, Pavord S, Howard R, Robinson S, Oakley L, Mackillop L, et al. Management of sickle cell disease in pregnancy. A British Society for Haematology guideline. Br J Haematol. 2021;194(6):980\u201395.","journal-title":"Br J Haematol"},{"issue":"1","key":"9244_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1182\/asheducation-2006.1.48","volume":"2006","author":"PS Swerdlow","year":"2006","unstructured":"Swerdlow PS. Red cell exchange in sickle cell disease. Hematology. 2006;2006(1):48\u201353.","journal-title":"Hematology"},{"issue":"1","key":"9244_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1182\/hematology.2023000498","volume":"2023","author":"S Kelly","year":"2023","unstructured":"Kelly S. Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease. Hematology. 2023;2023(1):646\u201352.","journal-title":"Hematology"},{"issue":"2","key":"9244_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/pbc.22985","volume":"57","author":"L Venkateswaran","year":"2011","unstructured":"Venkateswaran L, Teruya J, Bustillos C, Mahoney D Jr., Mueller BU. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer. 2011;57(2):294\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"9244_CR16","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1111\/j.1537-2995.2012.03659.x","volume":"52","author":"SK Wahl","year":"2012","unstructured":"Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion. 2012;52(12):2671\u20136.","journal-title":"Transfusion"},{"issue":"7","key":"9244_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/trf.13558","volume":"56","author":"RM Fasano","year":"2016","unstructured":"Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NLC, Meier ER. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients. Transfusion. 2016;56(7):1707\u201315.","journal-title":"Transfusion"},{"issue":"2","key":"9244_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.14383","volume":"176","author":"BA Davis","year":"2017","unstructured":"Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, et al. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol. 2017;176(2):192\u2013209.","journal-title":"Br J Haematol"},{"issue":"8","key":"9244_CR19","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","volume":"4","author":"MR DeBaun","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020;4(8):1554\u201388.","journal-title":"Blood Adv"},{"issue":"1","key":"9244_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1182\/hematology.2023000497","volume":"2023","author":"A Habibi","year":"2023","unstructured":"Habibi A, Benachi A, Lecarpentier E. Managing pregnancy in patients with sickle cell disease from a transfusion perspective. Hematology. 2023;2023(1):640\u20135.","journal-title":"Hematology"},{"issue":"3","key":"9244_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bjh.14993","volume":"183","author":"AK Malinowski","year":"2018","unstructured":"Malinowski AK, Parrish J, Shehata N, Ward R, Kuo KHM. Approach to transfusion in pregnant women with sickle cell disease: a survey of physicians. Br J Haematol. 2018;183(3):516\u20139.","journal-title":"Br J Haematol"},{"issue":"1","key":"9244_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13063-020-4212-8","volume":"21","author":"LL Oakley","year":"2020","unstructured":"Oakley LL, Awogbade M, Brien S, Briley A, Chorozoglou M, Drasar E, et al. Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial. Trials. 2020;21(1):347.","journal-title":"Trials"},{"issue":"1","key":"9244_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13063-023-07235-x","volume":"24","author":"PT Seed","year":"2023","unstructured":"Seed PT, Brien SB, Oakley LL, Robinson V, Sharif J, Thompson H, et al. Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial. Trials. 2023;24(1):225.","journal-title":"Trials"},{"issue":"16","key":"9244_CR24","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1182\/bloodadvances.2024012923","volume":"8","author":"E Oteng-Ntim","year":"2024","unstructured":"Oteng-Ntim E, Oakley LL, Robinson V, Brien S, Joseph J, Sharif J, et al. Prophylactic exchange transfusion in sickle cell disease pregnancy: a TAPS2 feasibility randomized controlled trial. Blood Adv. 2024;8(16):4359\u201369.","journal-title":"Blood Adv"},{"issue":"1","key":"9244_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40814-015-0026-y","volume":"1","author":"A O\u2019Cathain","year":"2015","unstructured":"O\u2019Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J, et al. Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers. Pilot Feasibility Stud. 2015;1(1):32.","journal-title":"Pilot Feasibility Stud"},{"issue":"3","key":"9244_CR26","doi-asserted-by":"publisher","first-page":"e095152","DOI":"10.1136\/bmjopen-2024-095152","volume":"15","author":"S Alizadeh","year":"2025","unstructured":"Alizadeh S, Nourizadeh R, Mohammadi E, Vedadhir A, Mehrabi E, Sarbakhsh P, et al. Women\u2019s perceptions of medicalised pregnancy and childbirth: an exploratory sequential mixed-method protocol study. BMJ Open. 2025;15(3):e095152.","journal-title":"BMJ Open"},{"issue":"3","key":"9244_CR27","doi-asserted-by":"publisher","first-page":"e0150205","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE. 2016;11(3):e0150205.","journal-title":"PLoS ONE"},{"key":"9244_CR28","doi-asserted-by":"publisher","first-page":"b3496","DOI":"10.1136\/bmj.b3496","volume":"339","author":"S Lewin","year":"2009","unstructured":"Lewin S, Glenton C, Oxman AD. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ. 2009;339:b3496.","journal-title":"BMJ"},{"issue":"3","key":"9244_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1473325002001003636","volume":"1","author":"MQ Patton","year":"2002","unstructured":"Patton MQ. Two decades of developments in qualitative inquiry: a personal, experiential perspective. Qual Soc Work. 2002;1(3):261\u201383.","journal-title":"Qual Soc Work"},{"key":"9244_CR30","unstructured":"Clarke V, Braun V, Hayfield N. Thematic analysis. In: Qualitative psychology: a practical guide to research methods. edn. 2015. pp. 222-248."},{"key":"9244_CR31","doi-asserted-by":"publisher","first-page":"c4587","DOI":"10.1136\/bmj.c4587","volume":"341","author":"A O\u2019Cathain","year":"2010","unstructured":"O\u2019Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341:c4587.","journal-title":"BMJ"},{"issue":"6","key":"9244_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bbmt.2020.03.014","volume":"26","author":"HL Cho","year":"2020","unstructured":"Cho HL, Kim SYH, Fitzhugh C, Hsieh M, Tisdale J, Grady C. Motivations and decision-making of adult sickle cell patients in high-risk clinical research. Biol Blood Marrow Transplant. 2020;26(6):1225\u201332.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"9244_CR33","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1182\/bloodadvances.2020003434","volume":"5","author":"LH Lee","year":"2021","unstructured":"Lee LH, Whisenton LH, Benger J, Lanzkron S. A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers. Blood Adv. 2021;5(23):5323\u201331.","journal-title":"Blood Adv"},{"issue":"1","key":"9244_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12884-019-2240-8","volume":"19","author":"TM Monteiro","year":"2019","unstructured":"Monteiro TM, Katz L, Bento SF, Amorim MM, Moriel PC, Pacagnella RC. Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis. BMC Pregnancy Childbirth. 2019;19(1):97.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"9244_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12884-020-03023-6","volume":"20","author":"C Yuill","year":"2020","unstructured":"Yuill C, McCourt C, Cheyne H, Leister N. Women\u2019s experiences of decision-making and informed choice about pregnancy and birth care: a systematic review and meta-synthesis of qualitative research. BMC Pregnancy Childbirth. 2020;20(1):343.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"9244_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/qshc.2005.015636","volume":"15","author":"S Kenyon","year":"2006","unstructured":"Kenyon S, Dixon-Woods M, Jackson CJ, Windridge K, Pitchforth E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006;15(2):98.","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"9244_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12884-015-0641-x","volume":"15","author":"K Oude Rengerink","year":"2015","unstructured":"Oude Rengerink K, Logtenberg S, Hooft L, Bossuyt PM, Mol BW. Pregnant womens\u2019 concerns when invited to a randomized trial: a qualitative case control study. BMC Pregnancy Childbirth. 2015;15(1):207.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"02","key":"9244_CR38","doi-asserted-by":"publisher","first-page":"069","DOI":"10.1055\/s-2003-38318","volume":"20","author":"MA Rodger","year":"2003","unstructured":"Rodger MA, Makropoulos D, Walker M, Keely E, Karovitch A, Wells PS. Participation of pregnant women in clinical trials: will they participate and why? Am J Perinatol. 2003;20(02):069\u201376.","journal-title":"Am J Perinatol"},{"key":"9244_CR39","doi-asserted-by":"crossref","unstructured":"Carroll K, Hudek N, Presseau J, Tunji-Ajayi L, Richards DP, Marlin S, Brehaut JC. A patient-centered, theory-guided approach toexamining the barriers and enablers to trial participation among people with SCD. Journal of Sickle Cell Disease. 2025;2(1):yoaf032.","DOI":"10.1093\/jscdis\/yoaf032"},{"issue":"4","key":"9244_CR40","doi-asserted-by":"publisher","first-page":"e080961","DOI":"10.1136\/bmjopen-2023-080961","volume":"14","author":"K Hardman","year":"2024","unstructured":"Hardman K, Davies A, Demetri A, Clayton G, Bakhbakhi D, Birchenall K, et al. Maternity healthcare professionals\u2019 experiences of supporting women in decision-making for labour and birth: a qualitative study. BMJ Open. 2024;14(4):e080961.","journal-title":"BMJ Open"},{"issue":"12","key":"9244_CR41","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/pd.5554","volume":"39","author":"AV Nik\u010devi\u0107","year":"2019","unstructured":"Nik\u010devi\u0107 AV, Dodd Z, Prior J, O\u2019Gorman N, Poon LC, Nicolaides KH. Reasons for accepting or declining participation in the ASPRE trial: a qualitative study with women at high risk of preterm pre-eclampsia. Prenat Diagn. 2019;39(12):1127\u201335.","journal-title":"Prenat Diagn"},{"key":"9244_CR42","doi-asserted-by":"publisher","first-page":"100698","DOI":"10.1016\/j.conctc.2021.100698","volume":"21","author":"M Sekhon","year":"2021","unstructured":"Sekhon M, Cartwright M, Lawes-Wickwar S, McBain H, Ezra D, Newman S, et al. Does prospective acceptability of an intervention influence refusal to participate in a randomised controlled trial? An interview study. Contemp Clin Trials Commun. 2021;21:100698.","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"9244_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1740774513519876","volume":"11","author":"C Haywood","year":"2014","unstructured":"Haywood C, Lanzkron S, Diener-West M, Haythornthwaite J, Strouse JJ, Bediako S, et al. Attitudes toward clinical trials among patients with sickle cell disease. Clin Trials. 2014;11(3):275\u201383.","journal-title":"Clin Trials"},{"issue":"Supplement 1","key":"9244_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1182\/blood-2024-194253","volume":"144","author":"B Andemariam","year":"2024","unstructured":"Andemariam B, Wufsus A, Hecht E, Trimnell C. Motivators and barriers for people with sickle cell disease participating in clinical trials: United States findings from the Listen Survey. Blood. 2024;144(Supplement 1):1139\u20131139.","journal-title":"Blood"},{"issue":"9","key":"9244_CR45","doi-asserted-by":"publisher","first-page":"e057141","DOI":"10.1136\/bmjopen-2021-057141","volume":"12","author":"MJ Berghs","year":"2022","unstructured":"Berghs MJ, Horne F, Yates S, Graham S, Kemp R, Webster A, et al. Black sickle cell patients\u2019 lives matter: healthcare, long-term shielding and psychological distress during a racialised pandemic in England \u2013 a mixed-methods study. BMJ Open. 2022;12(9):e057141.","journal-title":"BMJ Open"},{"issue":"4","key":"9244_CR46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/bjhp.12597","volume":"27","author":"B Volkmer","year":"2022","unstructured":"Volkmer B, Lorencatto F, Stanworth SJ, Hirani SP, Francis JJ. Blood transfusion in haematology: a qualitative exploration of patients\u2019 and healthcare professionals\u2019 perceptions. Br J Health Psychol. 2022;27(4):1241\u201374.","journal-title":"Br J Health Psychol"},{"issue":"suppl_7","key":"9244_CR47","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1093\/cid\/ciu726","volume":"59","author":"PM Frew","year":"2014","unstructured":"Frew PM, Saint-Victor DS, Isaacs MB, Kim S, Swamy GK, Sheffield JS, et al. Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Clin Infect Dis. 2014;59(suppl_7):S400\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4-5","key":"9244_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/13557858.2011.552712","volume":"16","author":"SM Bediako","year":"2011","unstructured":"Bediako SM, Moffitt KR. Race and social attitudes about sickle cell disease. Ethn Health. 2011;16(4\u20135):423\u20139.","journal-title":"Ethn Health"},{"issue":"20","key":"9244_CR49","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1056\/NEJMp2022125","volume":"383","author":"A Power-Hays","year":"2020","unstructured":"Power-Hays A, McGann PT. When actions speak louder than words \u2014 racism and Sickle Cell Disease. N Engl J Med. 2020;383(20):1902\u20133.","journal-title":"N Engl J Med"},{"key":"9244_CR50","doi-asserted-by":"crossref","unstructured":"Wu JK, McVay K, Mahoney KM, Sayani FA, Roe AH, Cebert M. Experiences with healthcare navigation and bias among adult women with sickle cell disease: a qualitative study. Quality of Life Research. 2024;33(12):3459-67.","DOI":"10.1007\/s11136-024-03805-x"},{"issue":"8","key":"9244_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/01612840.2018.1443530","volume":"39","author":"D Bulgin","year":"2018","unstructured":"Bulgin D, Tanabe P, Jenerette C. Stigma of Sickle Cell Disease: a systematic review. Issues Ment Health Nurs. 2018;39(8):675\u201386.","journal-title":"Issues Ment Health Nurs"},{"key":"9244_CR52","unstructured":"All-Party Parliamentary Group on Sickle Cell and Thalassaemia (SCTAPPG). No one\u2019s listening: an inquiry into the avoidable deaths and failures of care for sickle cell patients in secondary care. 2021."},{"key":"9244_CR53","unstructured":"National Institute for Health and Care Excellence (NICE). Sickle cell disease: managing acute painful episodes in hospital (CG143). In: Clinical guideline. London: NICE; 2012."},{"issue":"9","key":"9244_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1525-1497.1999.07048.x","volume":"14","author":"G Corbie-Smith","year":"1999","unstructured":"Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14(9):537\u201346.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"9244_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/13557858.2016.1182126","volume":"22","author":"A Smart","year":"2017","unstructured":"Smart A, Harrison E. The under-representation of minority ethnic groups in UK medical research. Ethn Health. 2017;22(1):65\u201382.","journal-title":"Ethn Health"},{"issue":"20","key":"9244_CR56","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.2018.17716","volume":"320","author":"K Heyrana","year":"2018","unstructured":"Heyrana K, Byers HM, Stratton P. Increasing the participation of pregnant women in clinical trials. JAMA. 2018;320(20):2077\u20138.","journal-title":"JAMA"},{"issue":"4","key":"9244_CR57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/13591053211037736","volume":"28","author":"CP Dwyer","year":"2023","unstructured":"Dwyer CP, Moses A, Rogers FM, Casey D, Joyce R, Hynes SM. A qualitative investigation of reasoning behind decisions to decline participation in a research intervention: a study-within-a-trial. J Health Psychol. 2023;28(4):374\u201387.","journal-title":"J Health Psychol"},{"issue":"1","key":"9244_CR58","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s13063-016-1626-4","volume":"17","author":"A Hughes-Morley","year":"2016","unstructured":"Hughes-Morley A, Young B, Hempel RJ, Russell IT, Waheed W, Bower P. What can we learn from trial decliners about improving recruitment? Qualitative study. Trials. 2016;17(1):494.","journal-title":"Trials"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:03:09Z","timestamp":1790704989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9244"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09244-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6577176\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received NHS ethics approval on 28 March 2019 from the London\u2013Surrey Borders Research Ethics Committee (REC reference 18\/LO\/2070). Written informed consent was obtained from all participants including consent to their anonymised verbatim quotes being included in publications, with verbal re-consent obtained at the start of the interviews.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1070"}}